Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype

Finotello, R ORCID: 0000-0002-1932-211X, Rodriguez, JM Monne, Vilafranca, M, Altimira, J, Ramirez, GA, Haines, A and Ressel, L ORCID: 0000-0002-6614-1223 (2017) Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype. VETERINARY AND COMPARATIVE ONCOLOGY, 15 (4). pp. 1393-1402.

Text Melanoma VCO draft R1.docx - Author Accepted Manuscript Download (82kB)

Abstract

Canine melanoma (CMM) more commonly affects the oral mucosa and the cutis. CMM shares several features with human melanomas (HMM), included resistance to a broad variety of antineoplastic chemotherapy agents. P-glycoprotein 1 (Pgp) expression is a well-recognized feature of multi-drug resistance and the purpose of this study was to investigate its expression in treatment naïve CMM. We also investigated Pgp association with tumour location and histological features. Histology records of CMM were retrieved, including patients from 2012-2014. Twenty-five cases of CMM were included in this study. Results revealed that Pgp is expressed in CMM and oral tumours were more likely to have a membranous Pgp expression (100%) than cutaneous tumours (66.6%) (P = 0.010). Cytoplasmic and nuclear Pgp expression could also be identified. Results of this study bring useful data that help in understanding one of the possible mechanisms responsible of intrinsic chemotherapy resistance in canine CMM.

Item Type:	Article
Uncontrolled Keywords:	canine cutaneous melanoma, canine oral melanoma, MDR1, Pgp170
Depositing User:	Symplectic Admin
Date Deposited:	27 Feb 2017 10:27
Last Modified:	19 Jan 2023 07:15
DOI:	10.1111/vco.12281
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3006067